Image

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting

Eligibility

Inclusion Criteria:

Patients

  • Aged ≥18 years at the time of enrollment in the study
  • Resident of the US, Germany, or Japan
  • Able to read, speak, and understand English, German or Japanese
  • Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC)

Physicians

  • Resident of the US, Germany, or Japan
  • Lung cancer-treating physician specialized in one of the following medical areas: oncology, pneumonology, thoracic surgery, or radiology
  • Treated at least three new patients with resectable NSCLC in the past year

Exclusion Criteria:

Patients

  • Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
  • Being diagnosed with another malignancy alongside NSCLC
  • Not willing to be audio-recorded during the interview

Physicians

  • Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
  • Not willing to be audio-recorded during the interview

Study details
    Non-small Cell Lung Cancer (NSCLC)

NCT06448793

Bristol-Myers Squibb

1 February 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.